AR069223A1 - ANTIHELMINTIC COMBINATION - Google Patents

ANTIHELMINTIC COMBINATION

Info

Publication number
AR069223A1
AR069223A1 ARP080104874A ARP080104874A AR069223A1 AR 069223 A1 AR069223 A1 AR 069223A1 AR P080104874 A ARP080104874 A AR P080104874A AR P080104874 A ARP080104874 A AR P080104874A AR 069223 A1 AR069223 A1 AR 069223A1
Authority
AR
Argentina
Prior art keywords
combination
antihelmintic
compositions
controlling
trichlorfon
Prior art date
Application number
ARP080104874A
Other languages
Spanish (es)
Inventor
Fabiando Peterson Lopes
Hyun Sun Cho
Alvimar Costa
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of AR069223A1 publication Critical patent/AR069223A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C07D235/32—Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composiciones para controlar parásitos, que comprenden una combinacion de ivermectina, abamectina, sulfoxido de albendazol y triclorfon, y el uso de tales composiciones en la preparacion de un medicamento para controlar endoparásitos. Reivindicacion 7: Uso de acuerdo con las reivindicaciones 4 a 6, caracterizado porque el animal huésped es una oveja o una cabra.Compositions for controlling parasites, which comprise a combination of ivermectin, abamectin, albendazole sulfoxide and trichlorfon, and the use of such compositions in the preparation of a medicament for controlling endoparasites. Claim 7: Use according to claims 4 to 6, characterized in that the host animal is a sheep or a goat.

ARP080104874A 2007-11-09 2008-11-07 ANTIHELMINTIC COMBINATION AR069223A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07120380 2007-11-09

Publications (1)

Publication Number Publication Date
AR069223A1 true AR069223A1 (en) 2010-01-06

Family

ID=39059330

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080104874A AR069223A1 (en) 2007-11-09 2008-11-07 ANTIHELMINTIC COMBINATION

Country Status (7)

Country Link
CN (1) CN101848710A (en)
AR (1) AR069223A1 (en)
AU (1) AU2008324095A1 (en)
BR (1) BRPI0820260A2 (en)
MX (1) MX2010004852A (en)
WO (1) WO2009060063A1 (en)
ZA (1) ZA201002315B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR079409A1 (en) * 2009-09-07 2012-01-25 Mukhopadhyay Debashis GRANULATED ANTIHELMINTIC PREPARATIONS AND SUNINISTER SYSTEMS
PL2793874T3 (en) 2011-12-20 2017-06-30 Ectin Research Ab Synergistic combination comprising avermectins and a nsaid for tumor inhibition
CN102743403A (en) * 2012-06-26 2012-10-24 格特生物制药（天津）有限公司 Parasite expelling tablet for domestic animals and preparation method thereof
CN102726443B (en) * 2012-07-12 2013-11-27 中国林业科学研究院亚热带林业研究所 Ivermectin and dipterex compound pesticide
RU2699799C1 (en) * 2019-01-10 2019-09-11 Федеральное государственное бюджетное учреждение науки Сибирский федеральный научный центр агробиотехнологий Российской академии наук (СФНЦА РАН) Antiparasitic composition and a method for use thereof for treating parasitosis of ruminant animals
CN113755610B (en) * 2021-10-08 2023-09-12 内蒙古自治区农牧业科学院 Gene for detecting sensitivity of haemonchus contortus to ivermectin and application
CN114452314A (en) * 2022-01-12 2022-05-10 河南百草元兽药有限公司 Albendazole ivermectin powder and preparation method thereof
CN114569561A (en) * 2022-03-28 2022-06-03 中牧实业股份有限公司黄冈动物药品厂 Albendazole ivermectin powder and preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1069032C (en) * 1997-03-27 2001-08-01 中国农业大学 Antiparasitic medicine containing avermectin/ivermectin for animals
AU2003900505A0 (en) * 2003-02-05 2003-02-20 Jurox Pty Ltd Anthelmintic composition

Also Published As

Publication number Publication date
AU2008324095A1 (en) 2009-05-14
CN101848710A (en) 2010-09-29
BRPI0820260A2 (en) 2015-05-26
MX2010004852A (en) 2010-06-02
WO2009060063A1 (en) 2009-05-14
ZA201002315B (en) 2010-11-24

Similar Documents

Publication Publication Date Title
AR069223A1 (en) ANTIHELMINTIC COMBINATION
DOP2010000304A (en) COMPOSITIONS AND METHODS OF PREPARATION AND USE OF THE SAME
PA8772101A1 (en) IMIDAZOL-TRIAZOLOPIRIMIDINAS REPLACED
BR112015011036A2 (en) heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
CL2008000862A1 (en) Compounds derived from triazolones, non-nucleoside reverse transcriptase inhibitors; pharmaceutical composition containing said compounds; and use of the compound to treat HIV-1 infection.
GT201400111A (en) SUBSTITUTED TRIAZOLOPIRIDINS
CL2009000349A1 (en) Compounds derived from 4,5-dihydro-oxazol-2-ylamine; preparation procedure; pharmaceutical composition; and its use for the treatment of Alzheimer's disease.
PE20150200A1 (en) FORMULATION OF ANTIBODIES
CL2007002635A1 (en) Quinazolinone and isoquinolinone derived compounds, modulators of hpa axis activity; pharmaceutical composition comprising them; and its use in the treatment and / or prevention related to stress or depression.
CL2011000195A1 (en) Compounds derived from 5-alkynyl pyrimidine, kinase inhibitors; pharmaceutical compositions comprising the compounds; and use of the compounds in the preparation of medicaments for the treatment of cancer.
ECSP11010818A (en) METHODS TO ADMINISTER TOPIC ANTIFUNGICAL FORMULATIONS FOR THE TREATMENT OF Fungal INFECTIONS
AR064614A1 (en) PRODUCT COMBINED TO CONTROL PARASITES IN ANIMALS
AR057946A1 (en) FORMULATION OF SUSTAINED RELEASE ZONISAMIDE
CL2008002430A1 (en) Benzenesulfonamide derived compounds, cathepsin c inhibitors; pharmaceutical composition comprising them; and its use for the treatment of copd.
GT200800187A (en) TETRAHYDROPIRIDOTIENOPIRIMIDINE COMPOUNDS AND PROCEDURES FOR THE SAME USE
CL2011002675A1 (en) Use of compounds derived from 9-purin-9-yl-3,4-dihydroxytetrahydrofuran-2-yl-methyl nitrate or sulfate to reduce intraocular pressure; ophthalmic pharmaceutical composition comprising the compounds; and ophthalmic formulation of topical use that includes them.
NI201000189A (en) SOLID MEDICINE FORMULATION WITH DELAYED RELEASE.
UY30214A1 (en) MODIFICATIONS OF (5S) -5- (4- (5-CHLORINE-PIRIDIN - 2-ILOXI) -PIPERIDINA-1-SULFONILMETIL) -5-METHYL-IMIDAZOLIDINE-2,4-DIONA, PROCESSES FOR PREPARATION, COMPOSITIONS THAT THE CONTAIN AND APPLICATIONS.
CL2007001748A1 (en) Compound derived from 2-arylamino-4-aminopyrimidines, c-alpha protein kinase inhibitors; pharmaceutical compositions containing them; and its use to treat or prevent diabetes, cancer, cardiovascular diseases and others.
GT201300125A (en) 1H-PIRAZOL-5-SUBSTITUTED SODIUM OLATO
CL2007002862A1 (en) USE OF THE EPIDERMIC GROWTH FACTOR (EGF) TO TREAT SENSITIVE-MOTOR, PAINFUL NEUROPATHY AND MANIFESTATIONS OF ISCHEMICAL NEURITIS; PHARMACEUTICAL COMPOSITION INCLUDED BY EGF; AND USE OF THE COMPOSITION BEFORE SUCH.
UY31128A1 (en) FORMULATION OF NEVIRAPINE OF PROLONGED RELEASE
UY29417A1 (en) ENDOPARASITICID AGENTS
CL2009000904A1 (en) Compounds derived from cyclohexyl sulfonamides having antagonist activity at the npy y5 receptor, pharmaceutical composition and pharmaceutical formulation comprising them.
PA8806501A1 (en) TRIAZOLOTRIAZINAS AND TRIAZOLOPIRAZINAS AND ITS USE

Legal Events

Date Code Title Description
FB Suspension of granting procedure